Differential response of tumor cell lines to inhibition of the mitotic checkpoint regulator and mitotic kinesin, CENP-E

P. Chua,Radhika Desai,S. Schauer,W. Cornwell,A. Gilmartin,D. Sutton,K. Wood

Published 2007 in Molecular Cancer Therapeutics

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2007
Venue
Molecular Cancer Therapeutics
Publication date
2007-11-01
Fields of study
Biology, Medicine
Identifiers
No identifiers available.
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer
2012cites this paper
The role of kinesin family proteins in tumorigenesis and progression
2010cites this paper
Kinesin motor proteins as targets for cancer therapy
2009cites this paper
Centromere-Associated Protein E: A Motor That Puts the Brakes on the Mitotic Checkpoint
2008cites this paper